Label discloses seven nutrient amounts; lutein and zeaxanthin are listed without amounts; the studied AREDS2 eye formula uses 10 mg and 2 mg of those two ingredients
AURORA, Colorado — October 9, 2026 — PhytoThrive Labs has published the Supplement Facts for VisiFlora, a once-daily vision-support dietary supplement, showing seven nutrients with disclosed amounts and fourteen ingredients that share a single 351 mg proprietary blend. The label lists lutein and zeaxanthin inside that blend without stating how much of each is present. The National Eye Institute’s AREDS2 formula, the best-known eye-supplement study formula, used 10 mg of lutein and 2 mg of zeaxanthin.
The capsule is vegetable-based, with one capsule as a serving and 30 capsules per bottle. In total, the label lists 21 active ingredient entries: seven disclosed nutrients and the fourteen blend ingredients. The disclosed amounts are vitamin A as beta carotene (450 mcg RAE), vitamin C (90 mg), vitamin E (15 mg), zinc (11 mg), selenium (20 mcg), copper (0.9 mg) and chromium (15 mcg). The blend lists taurine, ginkgo biloba leaf, eyebright, grape seed extract, Coleus forskohlii root, alpha lipoic acid, rutin, quercetin, bilberry extract, saffron extract, lycopene, lutein, zeaxanthin and astaxanthin.
The company states that no clinical trial has evaluated the finished capsule. The label lists no probiotic organism or prebiotic ingredient.
“A label should let a reader see what is in the capsule and how it compares with the research,” Kevin Moore, Lead Formater at PhytoThrive Labs. “We published the amounts we disclose, said plainly which ones we do not, and explained how the formula differs from the studied AREDS2 formula.”
How the Label Compares With AREDS2
The National Eye Institute’s Age-Related Eye Disease Studies (AREDS and AREDS2) tested specific formulas in people at high risk of advanced age-related macular degeneration (AMD). NEI describes the AREDS2 formula as intended for people with intermediate AMD or advanced AMD in one eye, not as a general vision enhancer. VisiFlora is not an AREDS2 formula.
If the 351 mg blend were divided evenly across its fourteen ingredients, which the label does not say, each would average about 25 mg. Real formulas rarely divide evenly, and the label does not allow a reader to check whether lutein and zeaxanthin reach the studied amounts.
Learn More About VisiFlora Ingredients on their official website.
What Published Research Shows
All research below is unaffiliated with PhytoThrive Labs and used different amounts, forms and populations.
Lutein and zeaxanthin. The AREDS2 trial in JAMA (AREDS2 Research Group, 2013) randomized more than 4,000 people at high risk of advanced AMD. Adding lutein and zeaxanthin to the formula did not significantly reduce progression to advanced AMD in the primary analysis, although secondary analyses suggested possible benefit in people with low dietary intake of these carotenoids and when the pair replaced beta-carotene.
Beta-carotene. The vitamin A in VisiFlora is supplied as beta-carotene. In the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (New England Journal of Medicine, 1994), 20 mg daily of beta-carotene was associated with a higher rate of lung cancer in male smokers. VisiFlora’s amount is much lower, but this is why smokers and former smokers are advised to check with a clinician before using beta-carotene supplements.
Bilberry. A systematic review in Survey of Ophthalmology (Canter and Ernst, 2004) examined placebo-controlled trials of bilberry anthocyanosides for night vision and found no reliable evidence of benefit. The National Center for Complementary and Integrative Health (NCCIH) likewise finds the evidence for bilberry in eye conditions insufficient.
Saffron. A small crossover trial in Investigative Ophthalmology & Visual Science (Falsini et al., 2010) gave 25 people with early AMD 20 mg of saffron daily for 90 days and reported improved retinal electrical responses. The study was small and short, and it measured a laboratory test rather than everyday vision.
Ginkgo. NCCIH notes that ginkgo has not been shown to prevent or slow cognitive decline, that evidence for eye conditions is limited, and that ginkgo can raise bleeding concerns, especially with blood thinners.
The company cites no research for eyebright, rutin, quercetin, taurine, lycopene, astaxanthin, alpha lipoic acid, grape seed, Coleus forskohlii or chromium in this release.
Ingredient Research Is Not Finished-Product Evidence
A study of one ingredient at one dose in one population does not show that a multi-ingredient capsule produces the same result. The company states that no clinical trial has evaluated VisiFlora, and this release makes no claim that it improves vision, treats an eye condition or matches the AREDS2 formula. Individual results vary.
Safety Information
The company recommends consulting a qualified healthcare professional before use for anyone who is pregnant, nursing, under 18, managing a medical condition or taking medication. Specific points:
-
Smokers and former smokers should discuss beta-carotene with a clinician.
-
People taking blood thinners, scheduled for surgery or with a seizure history should ask about ginkgo.
-
People taking blood-pressure medicine should ask about Coleus forskohlii.
-
People taking diabetes medicine should ask about alpha lipoic acid and chromium.
-
Anyone using other eye formulas or multivitamins should check for overlapping ingredients, since amounts add up.
When Eyes Need a Clinician, Not a Capsule
Sudden floaters, flashes of light, a curtain or shadow in vision, sudden vision loss or eye pain can signal conditions such as retinal detachment and need urgent professional evaluation. A dietary supplement is not a treatment for any of them, and regular eye examinations remain the basis of eye care.
Format and Directions
VisiFlora is a vegetable capsule with a labeled serving of one capsule daily. The company’s website says to take it with food. Directions on the current package take precedence over any online description or older third-party instructions.
Availability
VisiFlora is offered through its official website, and the company’s site states that charges appear under its payment processor’s name instead of the product name. Terms change over time, so the company advises reading the current package details, return policy and checkout terms before completing any order.
Frequently Asked Questions
What is on the VisiFlora label?
Seven disclosed nutrients and a 351 mg proprietary blend of fourteen ingredients, for 21 active entries in total.
Are the lutein and zeaxanthin amounts listed?
No. Both are inside the blend without individual amounts.
Is VisiFlora the same as the AREDS2 formula?
No. Its disclosed vitamin C, vitamin E, zinc and copper amounts differ from AREDS2, and its lutein and zeaxanthin amounts are not disclosed.
Does the label list a probiotic?
No probiotic organism or prebiotic ingredient is listed.
Has VisiFlora been clinically tested?
The company states that no clinical trial has evaluated the finished capsule.
Who should speak to a clinician first?
Anyone who is pregnant, nursing, under 18, managing a medical condition, taking medication or experiencing new vision changes.
About PhytoThrive Labs
PhytoThrive Labs is the distributor of VisiFlora, a once-daily vegetable capsule dietary supplement. The company is based in Aurora, Colorado.
Media Contact
Kevin Moore, Lead Formater at PhytoThrive Labs
19655 E 35th Dr #100, Aurora, CO 80011
support@getvisiflora.com
Website: getvisiflora.com
References
[1] AREDS2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA (2013).
[2] National Eye Institute. Nutritional supplements for age-related macular degeneration (AREDS2).
[3] Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med (1994).
[4] Canter PH, Ernst E. Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision: a systematic review of placebo-controlled trials. Surv Ophthalmol (2004).
[5] NCCIH. Bilberry.
[6] NCCIH. Ginkgo.
[7] Falsini B, et al. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci (2010).
[8] U.S. FDA. Dietary Supplement Labeling Guide.
Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Research on individual ingredients does not establish the effectiveness of the finished capsule. This release is not medical advice.
Affiliate Disclosure: The link in this release is a tracking link. The publisher may receive compensation from qualifying transactions, in accordance with 16 CFR Part 255.
